Join
Live feed
·
PRReleasevia Quantisnow
Abivax SA logo

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

ByQuantisnow·Wall Street's wire, on your screen.
ABVX· Abivax SA
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABVX (Abivax SA) and more on Quantisnow.